Cadonilimab is under clinical development by Akeso and currently in Phase II for Metastatic Renal Cell Carcinoma.

Cardinalizumab (Ketanil) is a bi-specific antibody acts as programmed death 1 protein (PD-1) antagonist and CTLA4 antagonist. It is formulated as solution for inravenous route of administration.

Diseases of the pancreas can mimic other medical conditions, and accurate diagnosis is crucial. With the increase in access ...

Today in Music History for Jan. 13: ...

More than half of cancer patients in whom the cancer spreads beyond the primary site have lung metastases. What makes the ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

A Texas man is suing his former employer after he says he was fired due to his cancer diagnosis. In 2014, the Harris County ...

Surgeon General Vivek Murthy issued a report highlighting the risk of seven types of cancer from alcohol consumption, calling ...

This geographical spread suggests broader systemic issues beyond regional healthcare differences, pointing to global ...

A new study has identified one of the reasons why cancer frequently spreads from elsewhere in the body to the lungs: an amino ...

A NEW diagnostic test which could transform how thyroid lumps are assessed, potentially sparing hundreds of patients from ...